Avalere Welcomes Industry Veteran Ashley Flint to Policy Team

  • This page as PDF

Summary

Ashley Flint brings 12 years of policy experience in the life sciences industry, with deep knowledge of prescription drug pricing, access, and reimbursement.

Avalere announces that Ashley Flint has joined the firm as a principal focused on drug policy. Ashley will advise life sciences clients on the impact of federal and state policy changes, with a focus on Inflation Reduction Act (IRA) implementation, drug pricing, Medicare Part D, and the 340B program.

Ashley says, “Successfully navigating challenges and opportunities in the US policy environment is now a critical business function for the life sciences industry to ensure its ability to continue bringing new therapies to patients. I can’t imagine a more exciting time to join the talented team at Avalere to help our clients navigate these shifting paradigms with robust analytics and creative policy solutions to inform business strategies.”

Before joining Avalere, Ashley served as director of US policy & analytics at AbbVie, where she led a team responsible for analyzing proposed federal and state policies related to above-brand market access issues and developing policy positions and strategies that advanced business priorities. Previously, she was a senior director for policy & research at PhRMA where she served as the Part D policy lead. She was also an associate at HCM Strategists, providing policy support to hospital and patient advocacy groups.

“The life sciences industry is facing so many important changes due to the IRA, including Part D redesign and Medicare negotiation,” says Miryam Frieder, co-director of Avalere’s Policy Practice. “Ashley knows what keeps our clients up at night because she’s been in their position. In addition to her industry perspective, she brings a rigorous analytic lens to the business implications of these IRA-related changes and the development of business strategies to help clients weather these changes.”

Ashley holds an MPP in health policy from The George Washington University and a BA in political science and psychology from Emory University.

Webinar | Election 2024: What’s at Stake for Healthcare? 

On August 14 at 1:30 PM ET, Avalere experts and guests will discuss the 2024 elections, exploring the candidates’ health policy approaches and implications for stakeholders. 

Learn More

Register
Back To Top